1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Arca Biopharma Inc (ABIO): Arca Biopharma: A Genetically Targeted Drug For … – Seeking Alpha

January 10, 2014Organ Failureadmin

Arca Biopharma Inc (ABIO): Arca Biopharma: A Genetically Targeted Drug For ...
Seeking Alpha
A Colorado-based biopharmaceutical company, Arca Biopharma (ABIO), has a genetically-targeted drug, Gencaro (bucindolol hydrochloride), for Atrial fibrillation (AF) in patients with heart failure (HF). The drug offers a personalized medicine approach ...
Traders Buzz: Arca Biopharma Inc(NASDAQ:ABIO), Questcor Pharmaceuticals ...Market News Call

all 5 news articles »

Post navigation

← Biologic Makers Thwart Generics: Winning Stocks [Pfizer Inc., Amgen, Inc … – Seeking Alpha Brain Death Raises Tough Questions – National Geographic →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos